Status:
COMPLETED
The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
AIDS
Eligibility:
All Genders
13-100 years
Brief Summary
This study will evaluate the role of certain gene variants on the onset and course of cytomegalovirus (CMV) retinitis-a severe infection affecting the eye-in patients with AIDS. Symptoms include blurr...
Detailed Description
Background: LSOCA is a prospective observational study of ocular complications in HIV-infected AIDS patients including those treated with highly active anti-retroviral treatment (HAART). In the abse...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Lymphocytes for DNA and relevant clinical data from properly consented subjects will be provided to the LGD for genotyping and analysis. No available subjects will be excluded.
- Diagnosis of AIDS according to the 1993 CDC diagnostic criteria (with or without clinical symptoms of CMV retinitis or other ocular complications of AIDS).
- Age 13 years or older
- Signed consent statement
- For minors, ages 13-17, signed Consent Statement (by parent/guardian) and Assent Statement (by adolescent and parent/guardian).
Exclusion
Key Trial Info
Start Date :
October 26 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 4 2021
Estimated Enrollment :
2232 Patients enrolled
Trial Details
Trial ID
NCT00341172
Start Date
October 26 2004
End Date
March 4 2021
Last Update
March 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205